SKOAP Study Updates

Most insurance companies approve and cover our study procedures.

Phase 1 treatments are commonly used for knee pain and usually do not require pre-authorization. However, some SKOAP Study participants may be prescribed a medication called duloxetine. This medication is typically covered by your insurance, but you will have to pay your usual copay.

Phase 2 treatments usually do require pre-authorization. There may be a copay that participants will be responsible for.  

That said, insurance coverage does vary by region and company. For specific questions, call the project coordinator at the closest SKOAP Study location using the contact information on the About Us page.

Minnesota’s AM950 KTNF recently hosted an in-depth conversation around the treatment of Knee Osteoarthritis and the large NIH SKOAP Study, a multi-center, multi-phased study.

Host Ken Haglind led the conversation on the “Living Healthy and Aging Well” radio show. He was joined by a group from the Department of Anesthesiology at the University of Minnesota deeply involved with the SKOAP Study:

• Clarence Shannon, MD, Pain Program Director and Site Principal Investigator for the SKOAP Study
• Candace Nelson, Clinical Research Manager
• Alicia Bulleri, Clinical Research Coordinator from the Dept. of Anesthesiology

Podcast: Play in new window

The SKOAP Study received Institutional Review Board approval and opened in mid-January at seven sites.

‍

These sites are now recruiting:

• Brigham and Women’s Hospital (Boston, MA)
• Johns Hopkins University (Baltimore, MD)
• University of California San Diego (San Diego, CA)
• University of Maryland Baltimore (Baltimore, MD)
• University of Utah (Salt Lake City, UT)
• University of Washington (Seattle, WA)
• Wake Forest University (Winston-Salem, NC)